| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
49,340,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile 4D Molecular Therapeutics is a clinical-stage gene therapy company engaging the development of product candidates using its targeted and evolved adeno-associated viruses vectors. Co. has built a portfolio of gene therapy product candidates, with five product candidates in clinical trials: 4D-125 for the treatment of X-linked retinitis pigmentosa, 4D-150 for the treatment of wet age-related macular degeneration, 4D-110 for the treatment of choroideremia, 4D-310 for the treatment of Fabry disease, and 4D-710 for the treatment of cystic fibrosis lung disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
850,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$13,600,000 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
21,145 |
791,941 |
797,938 |
955,783 |
| Total Sell Value |
$668,973 |
$16,684,699 |
$16,804,030 |
$20,280,103 |
| Total People Sold |
1 |
4 |
4 |
5 |
| Total Sell Transactions |
6 |
15 |
17 |
27 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bizily Scott |
Chief Legal and HR Officer |
• • – |
2023-06-08 |
4 |
OE |
$8.04 |
$30,150 |
D/D |
3,750 |
5,487 |
|
- |
|
| Bizily Scott |
Chief Legal and HR Officer |
• • – |
2023-06-01 |
4 |
AS |
$18.31 |
$41,143 |
D/D |
(2,247) |
1,737 |
|
- |
|
| Bizily Scott |
Chief Legal and HR Officer |
• • – |
2023-06-01 |
4 |
OE |
$6.49 |
$12,169 |
D/D |
1,875 |
3,984 |
|
- |
|
| Moretti August J |
Chief Financial Officer |
• • – |
2023-05-15 |
4 |
OE |
$9.41 |
$28,230 |
D/D |
3,000 |
11,045 |
|
- |
|
| Shabet Rose Sharon |
|
• • • |
2023-05-09 |
4 |
B |
$16.00 |
$13,600,000 |
I/I |
850,000 |
4,787,914 |
0.01 |
- |
|
| Kirn David |
Chief Executive Officer |
• • – |
2023-05-02 |
4 |
GA |
$0.00 |
$0 |
I/I |
600,000 |
600,000 |
|
- |
|
| Kirn David |
Chief Executive Officer |
• • – |
2023-05-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
600,000 |
1,259,153 |
|
- |
|
| Bizily Scott |
Chief Legal and HR Officer |
• • – |
2023-04-21 |
4 |
AS |
$20.00 |
$75,000 |
D/D |
(3,750) |
2,109 |
|
- |
|
| Bizily Scott |
Chief Legal and HR Officer |
• • – |
2023-04-21 |
4 |
OE |
$8.04 |
$30,150 |
D/D |
3,750 |
5,859 |
|
- |
|
| Chacko Jacob |
|
• • – |
2023-04-21 |
4 |
AS |
$20.05 |
$100,270 |
D/D |
(5,000) |
0 |
|
- |
|
| Chacko Jacob |
|
• • – |
2023-04-21 |
4 |
OE |
$9.41 |
$47,050 |
D/D |
5,000 |
5,000 |
|
- |
|
| Bizily Scott |
Chief Legal and HR Officer |
• – – |
2023-03-01 |
4 |
AS |
$19.30 |
$43,386 |
D/D |
(2,248) |
2,109 |
|
- |
|
| Bizily Scott |
Chief Legal and HR Officer |
• – – |
2023-03-01 |
4 |
OE |
$6.49 |
$12,169 |
D/D |
1,875 |
4,357 |
|
- |
|
| Kirn David |
Chief Executive Officer |
• • – |
2023-02-22 |
4 |
AS |
$20.22 |
$332,665 |
D/D |
(16,449) |
1,859,153 |
|
- |
|
| Kirn David |
Chief Executive Officer |
• • – |
2023-02-21 |
4 |
AS |
$20.93 |
$377,209 |
D/D |
(17,997) |
1,875,602 |
|
- |
|
| Kirn David |
Chief Executive Officer |
• • – |
2023-01-20 |
4 |
AS |
$20.19 |
$174,127 |
D/D |
(8,625) |
1,893,599 |
|
- |
|
| Kirn David |
Chief Executive Officer |
• • – |
2023-01-19 |
4 |
AS |
$20.03 |
$218,347 |
D/D |
(10,899) |
1,902,224 |
|
- |
|
| Moretti August J |
Chief Financial Officer |
• – – |
2022-12-21 |
4 |
OE |
$9.41 |
$28,230 |
D/D |
3,000 |
6,595 |
|
- |
|
| Kirn David |
Chief Executive Officer |
• • • |
2022-12-16 |
4 |
AS |
$22.66 |
$1,241,577 |
D/D |
(53,944) |
1,913,123 |
|
- |
|
| Kirn David |
Chief Executive Officer |
• • • |
2022-12-15 |
4 |
AS |
$23.56 |
$776,767 |
D/D |
(32,933) |
1,967,067 |
|
- |
|
| Bizily Scott |
Chief Legal and HR Officer |
• – – |
2022-12-01 |
4 |
AS |
$21.52 |
$136,725 |
D/D |
(6,000) |
2,482 |
|
- |
|
| Bizily Scott |
Chief Legal and HR Officer |
• – – |
2022-12-01 |
4 |
OE |
$6.49 |
$42,319 |
D/D |
5,625 |
6,607 |
|
- |
|
| Schaffer David |
Director |
– • – |
2021-10-22 |
4 |
AS |
$31.00 |
$58,893 |
D/D |
(1,900) |
901,215 |
|
- |
|
| Schaffer David |
Director |
– • – |
2021-10-21 |
4 |
AS |
$31.56 |
$720,156 |
D/D |
(22,820) |
903,115 |
|
- |
|
| Schaffer David |
Director |
– • – |
2021-10-20 |
4 |
AS |
$31.02 |
$358,771 |
D/D |
(11,565) |
925,935 |
|
- |
|
66 Records found
|
|
Page 2 of 3 |
|
|
